But LIC’s capital infusion is temporary though. LIC will have to reduce its stake to 15 per cent in five-seven years and this would ease its pain.
“This deal will help IDBI to come out of the stressed scenario (high NPAs). This, along with an expected government infusion, would help the bank deliver good returns,” said Asutosh Kumar Misra, analyst at Reliance Securities. This is also supported by the bank’s non-core asset selling. IDBI is likely to sell partial stake in IDBI Asset Management.
The bank would also be in a position to achieve its Basel-III capital adequacy requirements. IDBI’s total capital adequacy ratio (including capital conservation buffer), as of March 2018, stood at 10.4 per cent, below the minimum requirement of 11.5 per cent. Even if LIC puts in Rs 100 billion, IDBI’s capital adequacy would improve to about 15 per cent, keeping risk-weighted assets at the March 2018 level.